Dow Up2.00% Nasdaq Up1.66%

Regeneron Pharmaceuticals, Inc. (REGN)

-NMS
379.01 Up 11.77(3.20%) Feb 12, 4:00PM EST
|After Hours : 379.09 Up 0.08 (0.02%) Feb 12, 5:04PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Net Income 210,398   194,643   76,021   100,043  
Operating Activities, Cash Flows Provided By or Used In
Depreciation20,674  15,298  16,027  14,135  
Adjustments To Net Income108,581  74,048  102,177  108,327  
Changes In Accounts Receivables(44,190)(97,690)(321,063)(116,074)
Changes In Liabilities676,062  103,259  9,394  101,366  
Changes In Inventories(31,607)(43,920)(5,932)(9,983)
Changes In Other Operating Activities(47,065)(2,032)35,874  (8,917)
Total Cash Flow From Operating Activities 892,853   243,606   (87,502) 188,897  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(146,099)(239,893)(114,162)(117,542)
Investments(137,072)(131,756)(15,319)174,187  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities (283,171) (371,649) (129,481) 56,645  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock(364,358)39,552  (48,258)(106,270)
Net Borrowings(2,381)(107,273)(9,948)(159,799)
Other Cash Flows from Financing Activities(35,743)(14,738)(21,192)(91,718)
Total Cash Flows From Financing Activities (345,649) 10,690   76,171   (243,377)
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents 264,033   (117,353) (140,812) 2,165  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.